These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2527133)

  • 21. Comparison of conventional twice daily subcutaneous insulin administration and a multiple injection regimen (using the NovoPen) in insulin-dependent diabetes mellitus.
    Small M; MacRury S; Boal A; Paterson KR; MacCuish AC
    Diabetes Res; 1988 Jun; 8(2):85-9. PubMed ID: 3067951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patients.
    Bak JF; Nielsen OH; Pedersen O; Beck-Nielsen H
    Diabetes Res; 1987 Nov; 6(3):155-8. PubMed ID: 3325220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
    Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G
    Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A bolus/basal multiple injection regimen in type I diabetes. A multicentre trial using a new 'fountain-pen' device for short-acting human insulin as well as long-acting human insulin.
    Distiller LA; Robertson LI; Moore R; Bonnici F
    S Afr Med J; 1987 Jun; 71(12):749-52. PubMed ID: 3299758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients.
    Dunbar JM; Madden PM; Gleeson DT; Fiad TM; McKenna TJ
    Diabetes Care; 1994 Aug; 17(8):874-8. PubMed ID: 7956634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Monotard and Ultratard insulin at bedtime in a model of optimized insulin therapy in Italy.
    Martina V; Tagliabue M; Maccario M; D'Antona G; Camanni F
    Diabete Metab; 1989; 15(6):372-4. PubMed ID: 2697606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS).
    Little SA; Leelarathna L; Walkinshaw E; Tan HK; Chapple O; Lubina-Solomon A; Chadwick TJ; Barendse S; Stocken DD; Brennand C; Marshall SM; Wood R; Speight J; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JA
    Diabetes Care; 2014 Aug; 37(8):2114-22. PubMed ID: 24854041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of different insulin regimens on quality of life and metabolic control in insulin-dependent diabetics.
    Tallroth G; Karlson B; Nilsson A; Agardh CD
    Diabetes Res Clin Pract; 1989 Jan; 6(1):37-43. PubMed ID: 2649340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.
    Fanelli CG; Pampanelli S; Porcellati F; Rossetti P; Brunetti P; Bolli GB
    Ann Intern Med; 2002 Apr; 136(7):504-14. PubMed ID: 11926785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of treatment with continuous subcutaneous insulin infusion versus multiple daily insulin injections with bolus calculator in patients with type 1 diabetes.
    Pérez-García L; Goñi-Iriarte MJ; García-Mouriz M
    Endocrinol Nutr; 2015; 62(7):331-7. PubMed ID: 26234808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
    Roach P; Bai S; Charbonnel B; Consoli A; Taboga C; Tiengo A; Bolli G;
    Clin Ther; 2004 Apr; 26(4):502-10. PubMed ID: 15189747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Split-mixed insulin regimen with human ultralente before supper and NPH (isophane) before breakfast in children and adolescents with IDDM.
    Wolfsdorf JI; Laffel LM; Pasquarello C; Vernon A; Herskowitz RD
    Diabetes Care; 1991 Nov; 14(11):1100-6. PubMed ID: 1797498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Basic-bolus therapy of diabetic children and adolescents using Novo Pens].
    Schober E; Borkenstein M; Frisch H
    Wien Klin Wochenschr; 1987 May; 99(9):312-3. PubMed ID: 3300042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical usefulness of serum fructosamine and HbA1 as markers for metabolic control in patients with changing insulin regimens.
    Steen G; Weber RF
    Diabetes Res; 1990 Apr; 13(4):177-82. PubMed ID: 2134209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
    JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis.
    Benkhadra K; Alahdab F; Tamhane SU; McCoy RG; Prokop LJ; Murad MH
    Endocrine; 2017 Jan; 55(1):77-84. PubMed ID: 27477293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.
    Skyler JS; Weinstock RS; Raskin P; Yale JF; Barrett E; Gerich JE; Gerstein HC;
    Diabetes Care; 2005 Jul; 28(7):1630-5. PubMed ID: 15983312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing preference of insulin regimen in people with type 1 (insulin-dependent) diabetes.
    Perros P; Deary IJ; Frier BM
    Diabetes Res Clin Pract; 1998 Jan; 39(1):23-9. PubMed ID: 9597371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preference for a new prefilled insulin pen compared with the original pen.
    Garg S; Bailey T; DeLuzio T; Pollom D
    Curr Med Res Opin; 2011 Dec; 27(12):2323-33. PubMed ID: 21988614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.